Home Categories API (S)-Methyl2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
BD0665448

(S)-Methyl2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate , 98% , 113665-84-2

CAS NO.:113665-84-2

Empirical Formula: C16 H16 Cl N O2 S

Molecular Weight: 321.82

MDL number: MFCD05662337

EINECS: 601-269-2

Pack Size Price Stock Quantity
100mg RMB104.00 In Stock
250mg RMB166.40 In Stock
1g RMB413.60 In Stock
5g RMB1320.00 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

alpha  D20 +51.52° (c = 1.61 in methanol)
Boiling point: 423.7±45.0 °C(Predicted)
Density  1.317±0.06 g/cm3(Predicted)
storage temp.  2-8°C
solubility  DMSO: 50mg/ml in DMSO
form  Oil
pka 4.56±0.20(Predicted)
color  Colorless to light yellow
InChI InChI=1/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/s3
InChIKey GKTWGGQPFAXNFI-UJHUVDBMNA-N
SMILES [C@@H](C1C=CC=CC=1Cl)(N1CCC2SC=CC=2C1)C(=O)OC |&1:0,r|
CAS DataBase Reference 113665-84-2(CAS DataBase Reference)

Description and Uses

Clopidogrel was launched in the US as a potent inhibitor of platelet aggregation for the preventive management of secondary ischemic events, including MI, stroke and vascular deaths. Clopidogrel can be synthesized in 4 steps (including an optical resolution to the S active enantiomer) from 2-(2- ch1orophenyl)-glycine, the key step being the cyclization to thienopyridine with formaldehyde and acetic acid. Clopidogrel belongs to the original chemical class of Ticlopidine, but shows fewer side effects (in particular, bone-marrowsuppressing effects) at the dosage generally used. Like Ticlopidine, it is an Adenosine diphosphate (ADP) antagonist acting at the purinergic P2y receptor. In in vivo experiments with rabbits, Clopidogrel shows a maximal antiaggregant effect at 20mg/kg po, reducing adhesion of platelets to the vascular subendothelium ; moreover, it reduces myointimal thickening occuring after endothelial injury of rat carotid artery. Clopigrel does not affect platelet aggregation in vitro ; actually, its in vivo activity is highly dependent on hepatic metabolism. The results of a CAPRIE trial (Clopidogrel versus Aspirin in patients at risk of ischemic events) demonstrated that Clopidogrel was well tolerated and more effective than aspirin.

Sertraline metabolite

Safety

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338
Hazard Codes  Xn
Risk Statements  22-36/37/38
Safety Statements  26-36
Hazardous Substances Data 113665-84-2(Hazardous Substances Data)

RELATED PRODUCTS